Canadian Prostate Cancer Guide
The Canadian Cancer Survivor Network (CCSN) is a leader in patient participation in healthcare, with a mandate to educate the […]
Androgen Deprivation Therapy Educational Program
We are reaching out with an update on upcoming online classes for the Life On Androgen Deprivation Therapy (ADT) Educational […]
Brad’s Story
I had been getting my PSA (Prostate Specific Antigen) tested for a few years along with a DRE (digital rectal […]
Prostate Cancer Centre’s Man Van Program
The Man Van® is a mobile Prostate Specific Antigen (PSA) blood testing facility. There are two vans, one used primarily […]
A LOSS OF TRUST
This true story is being shared at the request of the deceased. Tom Lucas retired as a captain with the […]
If something doesn’t seem right, it probably isn’t:
Our Story: G. was very athletic, jogging, cycling 7000K a year, ate all the right foods, stayed out of the […]
Prostate Specific Antigen (PSA) Testing
Prostate Specific Antigen (PSA) Testing What It Is, Why You Should Start Getting Tested, and When to Begin. Prostate-specific antigen […]
May 2023
Includes: Increase in active surveillance, Future Directions in Imaging, Physician’s Advice for defusing Patient Anger, Transgender Women Screening Disparity, and more!
March 2022
Includes: The PREVENT Study, Dr. Philip Barber bio, our first OPEN MIC NIGHT, PROpel Suggests Adding Olaparib to Abi-raterone Improves Outcomes, Risk vs. Benefit for Active Surveillance for Patients with Intermediate-Risk Disease, and more!
Update on Biomarkers in Prostate Cancer
Tarek Bismar, MD, Professor of Pathology at the University of Calgary and Alberta Precision labs joins us again for an update on new research Dr. Bismar and has team have been undertaking to help us predict disease progression in the active surveillance population.